WASHINGTON DC – A major federal marijuana policy shift announced April 23 is much narrower than our earlier headlines suggested—and for Michigan’s $3 billion recreational cannabis market, the immediate impact is very limited.
The U.S. Department of Justice, working with the Drug Enforcement Administration, has moved to reclassify state-licensed medical marijuana as a less dangerous drug under federal law.
But the change applies only to medical cannabis, not adult-use recreational marijuana, and it is not yet final.
Medical Marijuana—Not Recreational
That distinction is critical.
Michigan operates one of the largest recreational cannabis markets in the country, generating more than $3 billion annually. But the DOJ’s current action does not apply to that market. Only to medical marijuana that accounts for less than 1 percent of monthly cannabis sales in Michigan.
“This is about medical marijuana,” said Scott Roberts, a cannabis attorney with Oak Law in Detroit. “Adult-use cannabis is not part of this announcement.”
Roberts said the move reflects a federal acknowledgment that cannabis has accepted medical value—but it stops well short of broader legalization.
What Happens Next: A Long Federal Process
The announcement is only the first step in a formal federal rulemaking process that could take months to complete.
Federal officials have scheduled an administrative hearing beginning June 29, where regulators will gather expert testimony and public input on whether and how marijuana should be more broadly rescheduled under the Controlled Substances Act.
That process includes:
- Review of scientific and medical evidence
- Testimony from industry, legal, and public health experts
- Potential revisions to the proposed rule
- Final determination by federal regulators
Legal experts say a final decision is unlikely before late 2026 at the earliest.
“This is not the final word,” Roberts said. “There’s still a full administrative process that needs to play out.”
Could Recreational Marijuana Be Included Later?
While adult-use cannabis is not part of the current action, Roberts said the upcoming hearing process could open the door to broader consideration.
“The federal government may also review whether recreational marijuana should be included in a future rescheduling decision,” he said.
That remains speculative—but it is one of the key questions the June hearings could begin to address.
For now, however, recreational cannabis remains federally illegal and unchanged by the DOJ announcement.
What Changes Now—And What Doesn’t
Even with the limited scope, the move could still have financial implications—particularly if marijuana is ultimately moved to Schedule III.
The most significant potential impact involves federal tax policy.
Under current law, cannabis businesses are subject to IRS Section 280E, which prevents companies dealing in Schedule I or II substances from deducting ordinary business expenses.
If marijuana is formally reclassified to Schedule III after the rulemaking process:
- That restriction would no longer apply
- Cannabis businesses could deduct standard operating costs
- Profitability across the industry could improve
However, because the current action is limited to medical marijuana—and not yet finalized—those benefits are not immediate and not guaranteed.
Banking Still a Barrier
One of the biggest misconceptions surrounding the announcement is that it could open the door to traditional banking.
It does not.
Even under Schedule III:
- Cannabis would remain a controlled substance
- Recreational marijuana would remain federally illegal
- Banks would still face compliance risks under federal law
Major institutions such as JPMorgan Chase, Bank of America, and Wells Fargo are unlikely to enter the market without additional legal protections.
That leaves the industry reliant on smaller financial institutions and alternative payment systems.
Payments Still a Workaround Economy
That disconnect is most visible at the checkout counter.
Many Michigan dispensaries still rely on so-called “cashless ATM” systems, where purchases are rounded up—often to the nearest $5—and budtenders must provide change.
Bill Shaw, managing partner of Genus Credit Services, said newer PIN-based debit systems are designed to eliminate that friction.
“Instead of rounding transactions, customers can pay the exact amount directly from their bank account using a PIN-based system,” Shaw said. “It cuts transaction time down to seconds and removes the need for cash handling or making change at the register.”
Shaw said some systems also shift transaction fees to the customer rather than the retailer and may offer small revenue-sharing opportunities for dispensaries.
Still, these systems operate within a workaround environment—not a fully normalized financial system.
The Bottom Line for Michigan
For now, the DOJ announcement is best understood as a medical marijuana policy shift with a long runway to implementation.
- ✔️ Applies only to medical marijuana
- ✔️ Begins a federal rulemaking process
- ✔️ Could lead to tax changes if finalized
- ❌ Does not include recreational cannabis
- ❌ Does not legalize marijuana federally
- ❌ Does not fix banking challenges
For Michigan’s dominant recreational market, the impact is minimal—for now.
The real decisions lie ahead in a federal process that will unfold over the coming months, with outcomes that remain uncertain.
Disclosure: Bill Shaw is an advertiser at MITechNews.Com.
